The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Reg - I think we should just give up now - if pi's don't get it then perhaps they should be buying premium bonds!
IMHO - those that held at COB yesterday and sold this morning will make the most profit.
Possibly buy back in when this bottoms out around12p but of course DYOR.
Swap - yes I was thinking the same thing.
I am still somewhat bemused by the fact that we are not seeing a steady increase in SP over the last 2 months - we have only received good news!
Reg and Geo - spot on. I do believe that the confusion is actually keeping the share price up as pi's are scared to sell - be interesting to see what happens tomorrow!
If you held at opening today you will be on the register tomorrow and will qualify - I have had this confirmed by Lloyds.
Checked with Lloyds and safe to sell today and retain divi.
I am happy with a blue day and another 2% or so on the share price - nice consolidation after the first half of last week!!
Thank you Si - or should I say Confucius!!
But being 20% down on our year high of 3 days ago is a bit galling - especially given that all our ducks are still very well aligned. I do think CF needs to come up with some statement to help stem the tide - which is well on its way out at the mo. GLA
;)
Let's embrace the positivity of our new comers. To my mind the more the merrier. At the end of the day we are all making or going to make some good money here. The new comers will only wish they were in when we were back at the single digit level!!
Good move and apologies for being somewhat facetious!!
I think most people on this BB would say don't bother!! LOL!!
Does beggar the question as to how far this can and will go. I am a long term investor - was in HVIVO from 3 years ago, now in good profit!! GLA
I wonder why GSK have not gone down the COVID challenge route for the Phase1/2 study they have just started??
Any clinical trial requires regulatory approval (MHRA), in addition the study protocol is submitted to the local ethics committee for approval - all standard pharma practice.
Given that the FTSE is taking a hammering we are doing well to be in the blue!!!
Exactly Ivy, this is also for all newly developed vaccines and is not specific or limited to Covid 19. It does, however, mean that HVIVO is in a great position wrt offering the facilities for the Major Pharma to undertake future challenge studies. So all good news!
Well I've topped up. Having been an HVIVO investor for a few years now, I am hoping that we will finally get what we have all been waiting for, a mulit bagger!! GLA
BDerby, go to Clintrials.gov.